Characteristics | Â |
---|---|
Age | 56 years old (32–77) |
Sex | |
 Male | 96 (99%) |
 Female | 1 (1%) |
T status | |
 1 | 4 (4%) |
 2 | 11 (11%) |
 3 | 29 (30%) |
 4 | 53 (55%) |
N status | |
 0 | 4 (4%) |
 1 | 27 (28%) |
 2 | 39 (40%) |
 3 | 27 (28%) |
Stage | |
 II | 4 (4%) |
 IIIA | 13 (13%) |
 IIIB | 14 (15%) |
 IIIC | 66 (68%) |
Grade | |
 1 | 23 (24%) |
 2 | 48 (49%) |
 3 | 26 (27%) |
Location | |
 Upper | 40 (41%) |
 Middle | 34 (35%) |
 Lower | 23 (24%) |
Radiotherapy dose | |
 42 Gy | 2 (2%) |
 44 Gy | 2 (2%) |
 46 Gy | 3 (3%) |
 48 Gy | 2 (2%) |
 50–50.4 Gy | 88 (91%) |
Cycles of chemotherapy | |
 1 cycle | 7 (7%) |
 2 cycles | 90 (93%) |